What Adial Pharmaceuticals Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 5 |
| Sells | 0 | 0 |
| Total trades | 0 | 15 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 437,667 |
| Disposed | 0 | 0 |
| Net activity | +0 | +437,667 |
Common stock only — 2 reported trades in the last 12 months are in a security these totals do not cover.
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Coastlands Capital Lp | 10% owner | Jul 16 | Open-market buy · P | +1,233 | $2.75 | +$3.39K | 388,308 |
| Coastlands Capital Lp | 10% owner | Jul 14 | Open-market buy · P | +2,000 | $2.65 | +$5.3K | 387,075 |
| Coastlands Capital Lp | 10% owner | Jul 10 | Open-market buy · P | +1,700 | $2.70 | +$4.59K | 385,075 |
| Coastlands Capital Lp | 10% owner | Jul 09 | Open-market buy · P | +10,053 | $2.79 | +$28K | 383,375 |
| Coastlands Capital Lp | 10% owner | Jun 29 | Open-market buy · P | +25,000 | $2.60 | +$65K | 373,322 |
| Davidson Matt | Chief Development Officer | Jun 12 | Grant / award · A | +232,417 | — | — | 297,491 |
| Davidson Matt | Chief Development Officer | Jun 11 | Grant / award · A | +101 | — | — | 1,923 |
| Davidson Matt | Chief Development Officer | Jun 11 | Grant / award · A | +1,822 | — | — | 1,822 |
| Davidson Matt | Chief Development Officer | Jun 11 | Grant / award · A | +3,427 | — | — | 3,427 |
| Davidson Matt | Chief Development Officer | Jun 11 | Grant / award · A | +61,647 | — | — | 61,647 |
| Goodman Tony | Chief Operating Officer | Apr 07 | Grant / award · A | +26,510 | — | — | 26,523 |
| Gilliland Robertson H. | Director | Apr 07 | Grant / award · A | +9,185 | — | — | 9,185 |
| Claiborne Cary J | Chief Executive Officer | Apr 07 | Grant / award · A | +37,985 | — | — | 40,417 |
| Shah Vinay | Chief Financial Officer | Apr 07 | Grant / award · A | +17,325 | — | — | 17,325 |
| Schuyler Kevin | Director | Apr 07 | Grant / award · A | +9,185 | — | — | 9,213 |
| Schuyler Kevin | Director | Sep 29 | Open-market buy · P | +700 | $2.74 | +$1.92K | 700 |
| Claiborne Cary J | Chief Executive Officer | May 23 | Grant / award · A | +420,000 | — | — | 1,520,000 |
| Stilley William B. Iii | Director | May 23 | Grant / award · A | +240,800 | — | — | 1,261,779 |
| Truluck Joseph | Chief Financial Officer | May 23 | Grant / award · A | +157,500 | — | — | 265,139 |
| Stilley William B. Iii | Director | Dec 30 | Disposition to Issuer · D | −166,667 | — | — | 1,020,979 |
Loading...
